Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

PaxMedica, Inc. - Common stock (OP: PXMD )

0.0310 UNCHANGED
Last Price Updated: 10:58 AM EST, Jan 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PaxMedica, Inc. - Common stock

Donald Trump’s Shock at Autism Figures Triggers Discussions on Possible Causes
Via Investor Brand Network
Topics Government
Exposures Political
Autism: What You Need to Know
Via Investor Brand Network
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
Via ACCESSWIRE
BioMedNewsBreaks – PaxMedica Inc. (PXMD) Secures Patent Approval in China for Autism Treatment
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Autism Prevalence Surges Globally, Raising Concerns Among Healthcare Experts
Via Investor Brand Network
Study Finds That Pollution Increases Autism Risk
Via Investor Brand Network
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection
Via ACCESSWIRE
Women with Autism Have Higher Odds of Being Misdiagnosed with BPD
Via Investor Brand Network
New Computational Model Explains Behavioral and Neural Differences in ASD
Via Investor Brand Network
Siblings of Autistic Kids Have Sevenfold Higher Risk of Autism
Via Investor Brand Network
Study Links Iron Deficiency to Disturbed Sleep Among Autism, ADHD Patients
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K
Via Investor Brand Network
PaxMedica Secures Immediate Exercise of Warrants
Via ACCESSWIRE
Yale Study Unravels Autism, Brain Growth Patterns
Via Investor Brand Network
BioMedNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) Provides Update on Its Response to Extraordinary Request to Provide PAX-101 to Malawi
Via Investor Brand Network
Topics Economy
Exposures Supply Chain
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Committed to Global Health, Potential Positive Impact of PAX-101
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Preparing for NDA Submission for Leading Drug Candidate
Via Investor Brand Network
Exposures Product Safety
Study Shows Autism More Prevalent in Kids Living in Congested Areas
Via Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Developing Treatments for Underserved Neurological Disorders
Via Investor Brand Network
Exposures Product Safety
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones
Via Investor Brand Network
Exposures Product Safety
New Research Suggests More Intervention May Not Increase Benefits for Autistic Kids
Via Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Marks Major Milestone in Preparations for NDA Submission, Global Suramin Supply
Via Investor Brand Network
Topics Supply Chain
Exposures Supply Chain
Researchers Say Brain ‘Overgrowth’ Could Contribute to Autism Development
Via Investor Brand Network
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.